People
Toronto researchers have helped make this city a world-leading hub for medical discovery. Learn more about the talented minds at the University of Toronto and leading Toronto hospitals who are transforming what’s possible in health innovation.
Prof. Christine Allen
Professor Allen is the Associate Vice-President and Vice-Provost, Strategic Initiatives, and serves as lead for the identification, assessment, prioritization and support of strategic, cross-divisional, excellence-driven, institutional initiatives. She is also the GlaxoSmithKline Chair in Pharmaceutics and Drug Delivery at the Leslie Dan Faculty of Pharmacy.
Prof. Cheryl Arrowsmith
Professor Arrowsmith is an internationally recognized expert in cancer-related structural biology and chemical biology and epigenetics. She has also led the Toronto site of the SGC since its inception, coordinating its epigenetic chemical probe program.
Prof. Leah Cowen
Professor Leah Cowen is the Canada Research Chair in Microbial Genomics & Infectious Disease, co-Director of the CIFAR Fungal Kingdom: Threats & Opportunities program, and former Chair of the Department of Molecular Genetics at the University of Toronto.
Prof. John Dick
Dr. Dick is a Senior Scientist at the Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine, University Health Network, Professor of Molecular Genetics, University of Toronto and Co-Leader, Acute Leukemia, Translational Research Initiative, Ontario Institute for Cancer Research, Toronto.
Dr. Kullervo Hynynen
Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre and a Senior Scientist at Sunnybrook Research Institute’s Odette Cancer Research Program. He is also a Professor in the Department of Medical Biophysics and the Institute of Biomedical Engineering at the Temerty Faculty of Medicine at the University of Toronto. With the overall goal of using technology to improve healthcare, his research interests centre on using focused ultrasound beams on tissue, with a particular focus in its application for the development of noninvasive therapy interventions.
Prof. Jean-Philippe Julien
Prof. Julien is a leader in the development of innovative antibody therapeutics and vaccines from molecular blueprints, including recent success targeting SARS-CoV-2, HIV-1 and malaria, and helps to coordinate EPIC’s vaccine and immunotherapy approaches.
Prof. Samira Mubareka
Dr. Mubareka is currently a Clinician-Scientist, Medical Microbiologist and Infectious Disease consultant at Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada. She is also Assistant Professor in Laboratory Medicine and Pathobiology at the University of Toronto, and the Infectious Diseases Lead at the Centre for Research Expertise in Occupational Diseases.
Prof. Scott Gray-Owen
Professor Gray-Owen has been Director of U of T’s Combined Containment Level 3 Unit (C-CL3) for more than a decade, providing regulatory and research oversight. He was awarded the Ontario Minister of Colleges and Universities’ 2020 Award of Excellence to recognize his leadership in the pandemic research response.
Prof. Milica Radisic
Prof. Radisic holds the Canada Research Chair in Functional Cardiovascular Tissue Engineering. Her research program includes projects in cardiac tissue engineering and regenerative medicine. In particular, she is focused on molecular mechanisms governing the formation of contractile cardiac tissue in vitro, and on practical strategies for treatment of myocardial infarction and heart failure through development of new biomaterials.